BTF3P10

Across TCGA pan-cancer cohorts, BTF3P10 RNA is linked to patient survival in 27 of 34 cancer types, making it the most broadly survival-associated BTF3P10 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher BTF3P10 RNA is associated with better overall survival. In most high-consensus cancer types, elevated BTF3P10 expression acts as an unfavorable survival marker, although some lineages such as KIRC and BRCA show a favorable association.

KIRC, MESO, and KICH are the cancer types where BTF3P10 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Median	All	0.717	0.540	<.001	146	view →
MESO	OS	Quartile	All	0.322	0.678	<.001	63	view →
KICH	OS	Tertile	III,IV	0.724	1.000	.006	43	view →
BRCA	OS	Median	II,III,IV	0.977	0.937	<.001	42	view →
LIHC	DFS	Median	All	0.215	0.352	<.001	42	view →
LUSC	OS	Tertile	II,III,IV	0.730	0.487	<.001	33	view →
DLBC	DFS	Median	All	0.341	1.000	.004	29	view →
ACC	OS	Tertile	III,IV	0.877	0.200	.007	16	view →
KIRP	DFS	Median	II,III,IV	0.939	0.486	.005	14	view →
LUAD	DFS	Tertile	III,IV	0.875	0.472	.001	14	view →
THYM	DFS	Tertile	III,IV	0.328	1.000	.008	12	view →
UCS	DFS	Tertile	IV	0.981	0.442	.024	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 27 lineages.

BTF3P10–KIRC (OS)

Open the KIRC breakdown →